Table 3.

Associations of immune cell subpopulations in patients with type 2 CRS with inflammatory markers, eGFR, and serum lipid levels.

Monocytes (N)	Lymphocytes (N)	CD8+ T-cells (%)
ESR r = 0.485 p = 0.00	eGFR r = 0.427 p = 0.007	HDL cholesterol r = 0.333, p = 0.04
CRP r = 0.402 p = 0.001
CD14++CD16- (N)	T-lymphocytes (N)	B-lymphocytes (N)
ESR r = 0.353, p = 0.030	eGFR r = 0.425 p = 0.007	Total cholesterol r = −0.336 p = 0.03
		LDL cholesterol r = −0.388, p = 0.01
CD14++CD16+ (N)	CD4+ T-cells (N)	B-lymphocytes (%)
ESR r = 0.378, p = 0.020	eGFR r = 0.439 p = 0.005	Total cholesterol r = −0.470 p = 0.003
CRP r = 0.476 p = 0.002		LDL cholesterol r = −0.441, p = 0.0005
CD14++CD16+ (%)	CD8+ T-cells (N)	Tregs (%)
CRP r = 0.319, p = 0.040	HDL cholesterol r = 0.318, p = 0.04	Triglycerides r = −0.377, p = 0.03

Correlations were assessed by Spearman’s or Pearson’s rank tests. Only correlations reaching statistical significance are presented. CRP, C-reactive protein; CRS, cardiorenal syndrome; eGFR, estimated glomerular filtration rate; ESR, erythrocyte sedimentation rate.